ADENOCARCINOMA OF THE PROSTATE
Clinical trials for ADENOCARCINOMA OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF THE PROSTATE trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
High-Dose radiation zaps prostate tumors with less damage to healthy tissue
Disease control OngoingThis study tests a special type of radiation called stereotactic body radiotherapy (SBRT) for men with high-risk prostate cancer that has not spread. The treatment delivers a very focused, high dose of radiation to the tumor to kill cancer cells while sparing nearby healthy tissu…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:01 UTC
-
New radiation cocktail aims to zap prostate cancer faster
Disease control OngoingThis early-stage study tests a new way to give radiation for intermediate risk prostate cancer. It combines two precise radiation methods: a short internal treatment (brachytherapy) followed by three weeks of focused external beams (SBRT). The goal is to find the safest dose and …
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
Promising prostate cancer combo under study
Disease control OngoingThis early-phase trial studies the safety and best way to give enzalutamide alongside radiation and hormone therapy for men with intermediate or high-risk prostate cancer. The goal is to see if this combination can better control the disease by blocking androgens that fuel cancer…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New adaptive hormone therapy aims to outsmart advanced prostate cancer
Disease control OngoingThis study tests an adaptive approach to hormone therapy for men with stage IV prostate cancer that still responds to hormone treatment. The goal is to control the cancer while possibly reducing side effects by adjusting treatment based on how the cancer responds. Only 17 men par…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New proton beam method targets hidden prostate tumors to prevent return
Disease control OngoingThis study tests whether a higher dose of proton radiation, precisely aimed at tumors seen on MRI, can better control high-risk prostate cancer. About 100 participants will receive radiation over 8-9 weeks, plus hormone therapy for 18 months. The main goal is to see if this appro…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 18, 2026 12:13 UTC